Speaker Prof. Dr. Ludwig Keilholz

Prof. Dr. Ludwig Keilholz

Professor med. Ludwig Keilholz, Chief Physician of the Clinic for Radiation Therapy, Klinikum Bayreuth, and the Deputy Head of the local oncological center, was educated at University of Erlangen. The Friedrich-Alexander-University Erlangen-Nuremberg appointed him Professor for his outstanding scientific achievements in the field of basic research in radiotherapy. His research in radiotherapy and immunology investigate the biological processes of inflammation under low-dose irradiation. He was member of one of the first research working groups on this subject in Germany in 1988. His specialties are cancer and inflammatory radiation. He is the author of over fifty scientific publications and holds lectures for medical students in the field of Radiotherapy and Radiation Biology. His research activities have kept him connected with Dr. Ulrich Randoll since their study days at the University of Erlangen. In his lecture on the “Developments in the Treatment of Cancer with Immune or Radioimmunotherapy,” he will present the current state of research, which he will illustrate critically.

Professor Keilholz, your connection to Dr. med. Randoll goes back to the beginning, when you were both at the University of Erlangen. Please tell us something about your time there together.

Yes, I have known Uli Randoll since our time together at the University of Erlangen and we have worked together many times ever. He was in Oral and Maxillofacial Surgery and I was in radiotherapy. We have researched together and have always thought outside of the box. Something that Uli Randoll has always admitted to. I have stayed in contact with Matrix Rhythm Therapy over the years. Uli Randoll and I have started research together in the field of immunology over thirty years ago. That is one reason why I submitted this topic. We both researched on neutrophilic granulocytes, which we called “Waldemar”. By using vital microscopy, we studied how to deal with a variety of influences and conditions, such as heat, rays, different constellations of being, the movement of speed, and how directional movement can influence granulocytes.

We sat in the lab for hours and forgot about time until Sema Randoll, who I also hold in high esteem, would intervene.

I’m really happy to be back in Ischia.

Not only are we both not rigidly attached to conventional medicine, we always look to find new approaches. We both also like to drink this wonderful yellow Italian beverage and discuss life in general. I greatly appreciate Uli Randoll 

Professor Keilholz, what things do you consider, when you are looking for new approaches?

Well, I come from the treatment of cancer patients, from Inflammation therapy, and I am, of course, interested in how overall well-being can stabilize a patient. What possibilities make a patient feel more comfortable overall. What are the other possibilities than those I offer. You also have to think outside the box. For example, which supplements can be used? Also, by questioning people, who do not come from conventional medicine, I find important approaches. You can’t go through life with blinders on. We always talk about evidence and studies, but you should always question yourself: does what you do really make sense?

I offered this topic, because immunotherapy, which is extremely current, is highly-sought-after cancer patients. Since 2015, the number of treated patients has exploded and is being discussed on every medicine conference.

Maybe you can already point out that it’s a good thing. On the other hand: Can we afford this therapy? One single drug costs between 100,000 and 120,000 euros per year and per patient. And you need combinations of two to four drugs. Another consideration is that there are side effects. We are talking about a 90 percent chance of side effects. Is that compatible with the quality of life? We have to discuss that, too in society. What does the general population think? And of course, this therapy is not used senselessly. It is to be used in desperate situations, often with quite amazing results

Can you tell us something about your focus on cancer and inflammatory radiation?

There are two different types of irradiation. One is the high-dose, destructive radiation that kills tumor cells. Then there is the other low dose radiation, which inhibits inflammation, and is used especially for inflamed joints and inflamed muscles. I deal with both.

During my presentation I would like to talk about immunotherapy. For that, I want to first go through the basics: How does the immune system actually work? What is the immune defense and how does it work for cancer, and why does it sometimes not work for cancer?

Immunotherapy is now the main use in cancer treatments. I want to ask here: Is it an asset in the treatment of cancer patients and which are the obstacles.

I see Matrix Rhythm Therapy as a special supplement. Cancer patients have so many side effects, some very stressful side effects. I always have seen very nice results by using Matrix Rhythm Therapy. For example, the patient who has a lot of pronounced edema and hardening just has less pain after Matrix Rhythm Therapy in combination with a good physiotherapist. I also had good results with fibrosis on the chest wall and with Lymphedema. However, it is important that the Matrix therapist has to be well trained.

Incidentally, I also have my own experience with Matrix Rhythm Therapy. Once I hit my finger with a hammer and it was swollen for weeks. Uli Randoll used Matrix Rhythm Therapy on me and the swelling was quickly under control.

I am someone who considers Matrix Rhythm Therapy to be very effective.

Contact details:

Prof. Dr. Ludwig Keilholz
Chief physician of the clinic and MVZ for radiotherapy
Klinikum Bayreuth GmbH
Preuschwitzer Strasse 101
95445 Bayreuth

ludwig.keilholz@klinikum-bayreuth.de